Latest Insider Transactions at Exact Sciences Corp (EXAS)
This section provides a real-time view of insider transactions for Exact Sciences Corp (EXAS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EXACT SCIENCES CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EXACT SCIENCES CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2022
|
Jacob A Orville EVP, GM, Screening |
BUY
Exercise of conversion of derivative security
|
Direct |
3,649
+26.38%
|
$270,026
$74.13 P/Share
|
|
Feb 15
2022
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
1,813
-32.37%
|
$143,227
$79.55 P/Share
|
|
Feb 15
2022
|
Jacob A Orville EVP, GM, Screening |
SELL
Open market or private sale
|
Direct |
940
-12.58%
|
$74,260
$79.55 P/Share
|
|
Feb 15
2022
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
14,409
-1.61%
|
$1,138,311
$79.55 P/Share
|
|
Feb 15
2022
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,839
-22.56%
|
$145,281
$79.55 P/Share
|
|
Feb 15
2022
|
Sarah Condella EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
938
-1.14%
|
$74,102
$79.55 P/Share
|
|
Feb 14
2022
|
D Scott Coward |
BUY
Exercise of conversion of derivative security
|
Direct |
3,972
+41.49%
|
$309,816
$78.33 P/Share
|
|
Feb 14
2022
|
Jacob A Orville EVP, GM, Screening |
BUY
Exercise of conversion of derivative security
|
Direct |
2,030
+21.36%
|
$158,340
$78.33 P/Share
|
|
Feb 14
2022
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
222,316
+8.15%
|
$7,114,112
$32.74 P/Share
|
|
Feb 14
2022
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,972
+32.77%
|
$309,816
$78.33 P/Share
|
|
Feb 14
2022
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,030
+2.4%
|
$158,340
$78.33 P/Share
|
|
Jan 14
2022
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,972
+48.74%
|
-
|
|
Jan 14
2022
|
Kevin T Conroy President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,407
+0.95%
|
-
|
|
Nov 01
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
16,922
-2.48%
|
$1,573,746
$93.88 P/Share
|
|
Oct 01
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
17,078
-2.45%
|
$1,588,254
$93.64 P/Share
|
|
Sep 01
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
18,978
-2.65%
|
$1,973,712
$104.42 P/Share
|
|
Aug 02
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
19,970
-2.71%
|
$2,136,790
$107.5 P/Share
|
|
Jul 30
2021
|
James Edward Doyle |
SELL
Open market or private sale
|
Direct |
2,640
-8.13%
|
$293,040
$111.17 P/Share
|
|
Jul 30
2021
|
Katherine S Zanotti |
SELL
Open market or private sale
|
Direct |
1,381
-3.82%
|
$153,291
$111.11 P/Share
|
|
Jul 29
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
38,361
-38.06%
|
$4,258,071
$111.0 P/Share
|
|
Jul 01
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
7,784
-1.04%
|
$957,432
$123.43 P/Share
|
|
Jun 30
2021
|
James Edward Doyle |
BUY
Grant, award, or other acquisition
|
Direct |
2,011
+5.83%
|
-
|
|
Jun 30
2021
|
Freda C Lewis Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,011
+16.1%
|
-
|
|
Jun 30
2021
|
Shacey Petrovic |
BUY
Grant, award, or other acquisition
|
Direct |
2,011
+19.4%
|
-
|
|
Jun 30
2021
|
Paul J Clancy |
BUY
Grant, award, or other acquisition
|
Direct |
2,567
+31.84%
|
-
|
|
Jun 30
2021
|
Pierre Jacquet Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,599
+18.11%
|
-
|
|
Jun 30
2021
|
Daniel J Levangie |
BUY
Grant, award, or other acquisition
|
Direct |
2,675
+13.13%
|
-
|
|
Jun 30
2021
|
Kathleen Sebelius |
BUY
Grant, award, or other acquisition
|
Direct |
2,699
+16.28%
|
-
|
|
Jun 30
2021
|
Katherine S Zanotti |
BUY
Grant, award, or other acquisition
|
Direct |
2,011
+5.27%
|
-
|
|
Jun 11
2021
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
13,102
+7.49%
|
$170,326
$13.36 P/Share
|
|
Jun 10
2021
|
Sarah Condella EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
5,450
-3.69%
|
$654,000
$120.0 P/Share
|
|
Jun 10
2021
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,950
+2.61%
|
$9,750
$5.03 P/Share
|
|
Jun 01
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
12,384
-1.63%
|
$1,374,624
$111.0 P/Share
|
|
May 03
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
19,240
-2.48%
|
$2,520,440
$131.09 P/Share
|
|
Apr 30
2021
|
D Scott Coward |
BUY
Grant, award, or other acquisition
|
Direct |
328
+16.76%
|
$20,992
$64.74 P/Share
|
|
Apr 30
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
206
+0.53%
|
$21,218
$103.22 P/Share
|
|
Apr 30
2021
|
Sarah Condella EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
328
+0.44%
|
$20,992
$64.74 P/Share
|
|
Apr 30
2021
|
Kevin T Conroy President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
328
+0.04%
|
$20,992
$64.74 P/Share
|
|
Apr 01
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
22,755
-2.85%
|
$3,003,660
$132.3 P/Share
|
|
Mar 18
2021
|
Paul J Clancy |
BUY
Grant, award, or other acquisition
|
Direct |
2,929
+50.0%
|
-
|
|
Mar 11
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
43,241
-52.99%
|
$5,621,330
$130.0 P/Share
|
|
Mar 11
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,241
+20.77%
|
$1,426,953
$33.03 P/Share
|
|
Mar 08
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,612
+10.73%
|
$96,852
$21.68 P/Share
|
|
Mar 05
2021
|
Graham Peter Lidgard Chief Science Officer |
SELL
Open market or private sale
|
Direct |
11,735
-25.8%
|
$1,419,935
$121.33 P/Share
|
|
Mar 03
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
2,664
-67.19%
|
$359,640
$135.02 P/Share
|
|
Mar 03
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,632
-6.42%
|
$355,320
$135.02 P/Share
|
|
Mar 02
2021
|
Sarah Condella EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,679
-2.22%
|
$231,702
$138.42 P/Share
|
|
Mar 02
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
9,796
-1.21%
|
$1,351,848
$138.42 P/Share
|
|
Mar 02
2021
|
D Scott Coward |
SELL
Open market or private sale
|
Direct |
4,126
-29.99%
|
$573,514
$139.36 P/Share
|
|
Mar 02
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,230
-4.79%
|
$587,970
$139.36 P/Share
|